Product Categories
| Country: | China |
|---|---|
| Tel: | 0531-88723173 |
| Mobile: | 18596073690 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| 2-[1-(4-BROMOPHENYL)-1-METHYLETHYL]-4,4-DIMETHYL-4,5-DIHYDROOXAZOLINE | C14H18BrNO | 192775-97-6 | Details |
| Oseltamivir Impurity1 | C20H32N2O4 | 3044729-56-5 | Details |
| 3,4-Dichloro-7-methylquinoline-6-carboxamide | Details |
| N-[[(5R)-3-[3-Fluoro-4-(4-Morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]Methyl]acetaMide | C16H20FN3O4 | 872992-20-6 | Details |
| Dimeric 7-ACA | Details |
| 2-Amino-6-chlorophenol | C6H6ClNO | 38191-33-2 | Details |
| Ipratropium Bromide Impurity K | C11H12O3 | 17838-69-6 | Details |
| Atenolol Impurity G | C14H21NO4 | 56392-14-4 | Details |
| Posaconazole Impurity 35 (Oxalate) | Details |
| Ethyl 2-[(methoxycarbonylethyl)(toluene-4-sulfonyl)amino]methyl-4-phenoxybenzoate | Details |
| 3-Oxo-2-quinuclidinecarboxylic acid ethyl ester | C10H15NO3 | 34286-16-3 | Details |
| N-(2-PyridylMethyl)glycine Ethyl Ester | C10H14N2O2 | 62402-24-8 | Details |
| Decarboxy Moxifloxacin 2 | C20H24FN3O2 | 929102-25-0 | Details |
| 2-Oxo-1,2-dihydro-[1,8]naphthyridine-3-carboxylic acid ethyl ester | C11H10N2O3 | 5174-90-3 | Details |
| Mirogabalin besylateSM1- impurity A | C9H14O2 | 344428-05-3 | Details |
| 1-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl][1,2,4]triazolo[4,3-a]pyridine-1-ium-3-ol/trazodone hydrochloride USP Impurity M | C19H23ClN5O | 157072-18-9 | Details |
| ALOIN | C21H22O9 | 8015-61-0 | Details |
| Metoclopramide EP impurity A | C16H24ClN3O3 | 5608-13-9 | Details |
| 2-Oxazolemethanol, 2,5-dihydro-α,2,4,5-tetramethyl- | C8H15NO2 | 171202-48-5 | Details |
| 2-(4-(2-hydroxyethyl)phenyl)-2-Methylpropanoic acid | C12H16O3 | 552301-45-8 | Details |
| 4β-Hydroxy Cholesterol-d4 (Major) | C27H46O2 | 1363529-44-5 | Details |
| Posaconazole Enantiomer | C37H42F2N8O4 | 2243785-97-7 | Details |
| methyl 2-methyl-2-(4-(2-(tosyloxy)ethyl)phenyl)propanoate | C20H24O5S | 1181267-30-0 | Details |
| 2-[4-(2-[4-(1H-benzimidazol-2-yl])piperidin-1-yl]ethyl)phenyl]-2-methylpropionic acid | C24H29N3O2 | 2099128-83-1 | Details |
| Pyrazine, tetramethyl-, 1-oxide (8CI,9CI) | C8H12N2O | 22978-83-2 | Details |
| N-nitroso-timolol | Details |
| 2,4-Diaminoanisole | C7H10N2O | 615-05-4 | Details |
| 8-((3R,4S)-4-ethylpyrrolidine-3-yl)-N-(2,2,2-trifluoroethyl)-3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazine-3-carboxamide | Details |
| BGLT-20-Pioglitazone Impurity PIO-II. | Details |
| Clindamycin EP Impurity C | C18H33ClN2O5S | 16684-06-3 | Details |
| Pentoxifylline Impurity J | C26H34N8O5 | 874747-30-5 | Details |
| 869 Impurity M | C33H38N4O7 | 185336-12-3 | Details |
| Methyl 2-(4-(2-hydroxyethyl)phenyl)-2-methylpropionate | C13H18O3 | 1000536-33-3 | Details |
| 8-Chloro-11-fluoro-6,11-dihydro-11-(4-piperidinyl)-5H-benzo[5,6]cyclohepta[1,2-b]pyridine | C19H20ClFN2 | 298220-99-2 | Details |
| Metoclopramide EP impurity H | C9H9NO4 | 50-86-2 | Details |
| 2-Anthracenecarboxaldehyde, 9,10-dihydro-4,5-dihydroxy-9,10-dioxo- | C15H8O5 | 154658-30-7 | Details |
| N-Nitroso Anatabine | C10H11N3O | 887407-16-1 | Details |
| 4-[1-(2-methoxy-ethyl)-1H-benzimidazole-2-yl]-piperidin-1-carboxylic acid tert-butyl ester | C20H29N3O3 | 1815602-35-7 | Details |
| L-Cefadroxil | C16H17N3O5S | 144790-28-3 | Details |
| Afatinib maleate impurity I-G | 2983348-69-0 | Details |
| Ethyl 2-(chloromethyl)-4-phenoxybenzoate | Details |
| 2,3,5-trimethyl-4-nitro-1-oxidopyridin-1-ium(SM2-2) | C8H10N2O3 | 86604-79-7 | Details |
| BM1-C | C7H3Cl2NO4 | 13300-63-5 | Details |
| 2,3-Difluoro-4-nitroaniline | C6H4F2N2O2 | 1781140-23-5 | Details |
| Ibuprofen-d3 | C13H15D3O2 | 121662-14-4 | Details |
| 2-[(4-Acetylphenyl)methyl]cyclopentan-1-one | C14H16O2 | 96824-28-1 | Details |
| 4-(3-chloro-4-ureidophenoxy)-7-methoxyquinoline-6-carboxamide | C18H15ClN4O4 | 417719-51-8 | Details |
| BM2-d | C12H8N2O5 | 002486-07-9 | Details |
| 1-((dimethylamino)methyl)-7-phenoxyisoquinolin-4-ol | C16H13NO2 | 2756726-89-1 | Details |
| cefixime | C16H15N5O7S2 | 108691-83-4 | Details |
| N-deacetyllappaconitine | C30H42N2O7 | 11033-64-0 | Details |
| Ilaprazole | C19H18N4O2S | 172152-36-2 | Details |
| 3-Amino-2-chlorophenol | C6H6ClNO | 56962-01-7 | Details |
| NA | Details |
| 1-(3,5-Dihydroxyphenyl)-2-[(1,1-diMethylethyl)(phenylMethyl)aMino]ethanone HydrobroMide | C19H23NO3 | 94109-61-2 | Details |
| Thioctic Acid Impurity H | C8H14O3S2 | 188783-96-2 | Details |
| Axitinib Sulfoxide | C22H18N4O3S | 1348536-59-3 | Details |
| 5-[(4-amino-2-carboxyphenyl)amino]-2-hydroxybenzoic acid | C14H12N2O5 | 1797983-23-3 | Details |
| Metoclopramide EP impurity B | C11H12ClNO4 | 4093-31-6 | Details |
| Leucoson | C14H17NO4S | 1950-36-3 | Details |
| Afatinib Impurity des-EJA | C22H20ClFN4O3 | 2223677-64-1 | Details |
| DEFLAZACORT | C23H29NO4 | 13649-88-2 | Details |
| N-hydroxyaniline control | C6H7NO | 100-65-2 | Details |
| 4-methoxy-2,3,5-trimethylpyridine 1-oxide(SM2-3 ) | C9H13NO2 | 86604-80-0 | Details |
| Cycloocta[b]pyridine, 2-chloro-5,6,7,8,9,10-hexahydro-4-phenyl- | C17H18ClN | 132813-13-9 | Details |
| Lincomycin Impurity B | C17H32N2O6S | 2520-24-3 | Details |
| METHYL2-(CHLOROMETHYL)PHENYL)PROPIONATE(MIXTURE) | C11H13ClO2 | 80530-54-7 | Details |
| 2-(4-chloromethyl-phenyl)-propionic acid ethyl ester | C12H15ClO2 | 43153-03-3 | Details |
| BGLT-18-Pioglitazone Impurity PGR-II. | Details |
| tert-butyl 4-(1-(2-ethoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidine-1-carboxylate | C21H31N3O3 | 1181267-36-6 | Details |
| Cinacalcet Impurity D | C32H31F6N | 1271930-15-4 | Details |
| Clindamycin eighteen carbonate salt control | C36H67ClN2O6S | 1123211-70-0 | Details |
| 4-Methoxy-1,2-phenylenediamine（SM1-1） | C7H10N2O | 102-51-2 | Details |
| N-Nitrosoanabasine | C10H13N3O | 1133-64-8 | Details |
| 4-[3-Chloro-4-[[(cyclopropylamino)carbonyl]amino]phenoxy]-N-cyclopropyl-7-methoxy-6-quinoline carboxamide | C24H23ClN4O4 | 417717-22-7 | Details |
| 4-Chloro-2-(propylthio)pyrimidine-5-amine (MDIP-15) | C7H10ClN3S | 2518048-22-9 | Details |
| Phenylmethyl(3S,4S)-3-[2-[(ethoxycarbonyl)[5-[(4-methylphenyl)sulfonyl]-5H-pyrrolo[2,3-B]pyrazine-2-yl]amino]acetyl]-4 ethyl 1-pyrrolidincarboxylate | C32H35N5O7S | 2715120-95-7 | Details |
| Isaconazole sulfate impurity BAL30078 | Details |
| 2-Methoxy-5-nitroaniline(SM1-7) | C7H8N2O3 | 99-59-2 | Details |
| 2-Chloro-4-(tert-pentyl)phenol | C11H15ClO | 5323-65-9 | Details |
| Cycloocta[b]pyridine, 2-chloro-5,6,7,8,9,10-hexahydro-4-(4-methoxyphenyl)- | C18H20ClNO | 132813-20-8 | Details |
| chlorosulfanylthiohypochlorite,4-(2-methylbutan-2-yl)phenol | C11H16Cl2OS2 | 68555-98-6 | Details |
| DL-Threitol | C4H10O4 | 7493-90-5 | Details |
| N-YXIPD | C6H10N2O | 3053220-60-0 | Details |
| NA | Details |
| 2-[3-[4-(3,4-dichlorophenyl)piperazine-1-yl]propyl][1,2,4]triazol[4,3-a]pyridine-3(2H)-one | Details |
| 3-[4-(3-chlorophenyl)piperazin-1-yl]propan-1-ol | C13H19ClN2O | 32229-98-4 | Details |
| 1-NaphthaleneMethanaMine, 5,6,7,8-tetrahydro-α-Methyl-, (αR)- | C12H17N | 851984-49-1 | Details |
| Paliperidone Impurity J | C11H13ClN2O2 | 1138463-56-5 | Details |
| 3-[2-(methylamino)ethyl]phenol hydrobromide | C9H14BrNO | 61186-06-9 | Details |
| (S)-Phenylephrine hydrochloride | C9H14ClNO2 | 939-38-8 | Details |
| (3R,4R)-3-(2-bromoacetyl)-4-ethylpyrrolidine-1-carboxylate | Details |
| 2-Nitropropane-1,3-Diol | C3H7NO4 | 1794-90-7 | Details |
| Rivaroxaban associated impurity 1 | C5H2Cl2O2S | 31166-29-7 | Details |
| Eplerenone EP Impurity D | C23H28O6 | 209253-82-7 | Details |
| 2-[4-(2-{4-[1-(2-ethoxyethyl)-1H-benzimidazole-2-yl]-piperidine-N-oxo-1-yl}-ethyl)-phenyl]-2-methylpropionic acid | C28H37N3O4 | 2069238-47-5 | Details |
| BM1-d | C6H3ClN2O4 | 97-00-7 | Details |
| Axitinib Acid | C21H14N3O2S- | 319462-34-5 | Details |
| Oseltamivir Impurity2 | C9H12N2O3 | 94154-89-9 | Details |
| O-toluenesulfonic acid (2-methylbenzenesulfonic acid) | C7H8O3S | 88-20-0 | Details |
| Product Total： Product Page： | ||||
| 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 | ||||